Farmak entered the list of “202 largest private companies of Ukraine” prepared by Forbes Ukraine for the fourth time.
The “Champions of Business” rating includes the largest private companies of Ukraine with a combined annual turnover of over UAH 5.1 trillion. Their total revenue in 2025 increased by 11%, and their combined profit increased by 3%.
The rating is based on the financial results of companies for 2025. The main ranking criterion was the annual turnover. To prepare the list, Forbes used financial statements, open data, including YouControl, and its own calculations. The list includes private non-financial companies operating in various sectors of the economy.
Farmak’s revenue in 2025 was UAH 13.3 billion, and the profit was UAH 2.1 billion. The company remains the industry leader in Ukraine, produces drugs for the treatment of diseases in 14 therapeutic groups, constantly updates its product portfolio and provides patients with modern drugs. The company remains one of the largest taxpayers in the pharmaceutical industry: in 2025, the company paid 1.6 billion in taxes and fees to budgets at all levels.
The company continues to develop and invest in strengthening its production and technological potential even in war conditions, and continues to produce about 20 new drugs every year. In 2026, Farmak completed an important stage of digital transformation by implementing a modern integrated SAP S/4HANA ERP system for business management.
Other rating participants include Metinvest, DTEK, ATB, MHP, Astarta and others.
